Stanniocalcin-1 (STC1) is a secreted glycoprotein whose increasing expression is linked to poor prognosis, progression, and metastasis of a variety of tumors, such as breast cancer (Chang et al., 2015), ovarian cancer (Zhang C. et al., 2019), and colon cancer (Pena et al., 2013). This evidence concerns the gene STC1 and ovarian cancer.